PL1817347T3 - Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu - Google Patents

Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu

Info

Publication number: PL1817347T3
Authority: PL; Poland
Prior art keywords: divinylsulfone; cross; hyaluronic acid; linking hyaluronic; linking
Prior art date: 2004-11-24

Application number

PL05804061T

Other languages

English (en)

Inventor

Fanny Longin

Khadija Schwach-Abdellaoui

Original Assignee

Albumedix As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-24

Filing date

2005-11-24

Publication date

2017-10-31

2005-11-24 Application filed by Albumedix As filed Critical Albumedix As

2017-10-31 Publication of PL1817347T3 publication Critical patent/PL1817347T3/pl

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
238000004132 cross linking Methods 0.000 title 1
AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Birds (AREA)
Dermatology (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Ophthalmology & Optometry (AREA)
Materials Engineering (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL05804061T 2004-11-24 2005-11-24 Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu PL1817347T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200401824		2004-11-24
EP05804061.9A EP1817347B1 (en)	2004-11-24	2005-11-24	Method of cross-linking hyaluronic acid with divinylsulfone
PCT/DK2005/000753 WO2006056204A1 (en)	2004-11-24	2005-11-24	Method of cross-linking hyaluronic acid with divinylsulfone

Publications (1)

Publication Number	Publication Date
PL1817347T3 true PL1817347T3 (pl)	2017-10-31

Family

ID=36051535

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05804061T PL1817347T3 (pl)	2004-11-24	2005-11-24	Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu

Country Status (8)

Country	Link
US (3)	US8481080B2 (pl)
EP (1)	EP1817347B1 (pl)
CN (1)	CN101107270B (pl)
DK (1)	DK1817347T3 (pl)
ES (1)	ES2636998T3 (pl)
PL (1)	PL1817347T3 (pl)
PT (1)	PT1817347T (pl)
WO (1)	WO2006056204A1 (pl)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
FR2909560B1 (fr) *	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	Gel d'acide hyaluronique pour injection intradermique
SI2107913T1 (sl)	2006-12-22	2012-05-31	Croma Pharma Ges M B H	Uporaba tioliranih polisaharidov za tkivno avgmentacijo
JP2008255061A (ja) *	2007-04-06	2008-10-23	Shiseido Co Ltd	可溶性架橋ヒアルロン酸含有眼用組成物
AU2008256819A1 (en) *	2007-05-23	2008-12-04	Allergan, Inc.	Cross-linked collagen and uses thereof
US20110077737A1 (en) *	2007-07-30	2011-03-31	Allergan, Inc.	Tunably Crosslinked Polysaccharide Compositions
KR100990301B1 (ko)	2007-09-28	2010-10-26	가부시키가이샤 시세이도	팽윤성 가교 히알루론산 분말과 그 제조 방법
US8697044B2 (en)	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
EP2818184B1 (en)	2007-11-16	2018-10-31	Allergan, Inc.	Compositions and methods for treating Purpura
US8394782B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8394784B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
US9109051B2 (en) *	2007-12-19	2015-08-18	Evonik Goldschmidt Gmbh	Crosslinked hyaluronic acid in emulsion
US8450475B2 (en)	2008-08-04	2013-05-28	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en)	2008-09-02	2014-12-11	Allergan, Inc.	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
DK2413894T3 (en) *	2009-04-02	2017-04-03	Allergan Inc	HIGHLY FORMED HYDROGLES FOR SOFTWARE STRENGTH
US9371402B2 (en) *	2009-04-09	2016-06-21	Scivision Biotech Inc.	Method for producing cross-linked hyaluronic acid
FR2945293B1 (fr)	2009-05-11	2011-06-17	Teoxane	Procede de preparation d'un gel reticule.
US8790702B2 (en) *	2009-07-30	2014-07-29	Carbylan Therapeutics, Inc.	Modified hyaluronic acid polymer compositions and related methods
CZ302503B6 (cs)	2009-12-11	2011-06-22	Contipro C A.S.	Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ2009836A3 (cs)	2009-12-11	2011-06-22	Contipro C A.S.	Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en)	2010-03-12	2013-11-19	Allergan Industrie, Sas	Fluid compositions for improving skin conditions
DK2550027T4 (da)	2010-03-22	2019-05-13	Allergan Inc	Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
AU2010350075B2 (en) *	2010-03-30	2016-03-03	Histocell, S.L.	New biomaterial from Wharton's jelly umbilical cord
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
FR2968305B1 (fr)	2010-12-06	2014-02-28	Teoxane	Procede de preparation d'un gel reticule
CZ302994B6 (cs)	2010-12-31	2012-02-08	Cpn S.R.O.	Hyaluronová vlákna, zpusob jejich prípravy a použití
ES2537411T3 (es)	2011-04-20	2015-06-08	Carbylan Therapeutics, Inc.	Composiciones formadoras de gel in situ
CN102757572A (zh) *	2011-04-28	2012-10-31	上海其胜生物制剂有限公司	一种具有双抗特性(抗高温、酶解)的无颗粒化交联透明质酸钠凝胶的制备方法
ES2738208T3 (es)	2011-06-03	2020-01-20	Allergan Ind Sas	Composiciones de relleno dérmico que incluyen antioxidantes
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
RS62488B1 (sr)	2011-08-10	2021-11-30	Glycores 2000 Srl	Unakrsno povezani hijaluronat male molekulske težine, otporan na razgradnju
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
CZ303879B6 (cs)	2012-02-28	2013-06-05	Contipro Biotech S.R.O.	Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs)	2012-08-08	2014-06-11	Contipro Biotech S.R.O.	Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
FR2997014B1 (fr)	2012-10-24	2015-03-20	Teoxane	Composition sterile dermo-injectable
FR2997085B1 (fr)	2012-10-24	2015-05-29	Teoxane	Procede de preparation d'un gel reticule
CZ304654B6 (cs) *	2012-11-27	2014-08-20	Contipro Biotech S.R.O.	Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
WO2014096257A1 (en) *	2012-12-19	2014-06-26	Novozymes Biopharma Dk A/S	Freeze-dried cross-linked hyaluronic acid sponge
US20200230033A1 (en) *	2013-01-21	2020-07-23	Paean Aesthetics Inc.	Micro-spicule composition to control its shape and method for producing the same
AU2014301493B2 (en) *	2013-06-28	2018-11-29	Galderma S.A.	A process for preparing a cross-linked hyaluronic acid product
KR102277655B1 (ko) *	2013-09-27	2021-07-15	앙테이스 에스.아.	분말 형태로 첨가되는 리도카인 및 알칼리 제제를 포함하며 히알루론산을 기본 성분으로 하고 열에 의해 살균된, 주입가능한 하이드로겔의 수득 방법
CZ305153B6 (cs)	2014-03-11	2015-05-20	Contipro Biotech S.R.O.	Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs)	2014-06-30	2016-01-13	Contipro Pharma A.S.	Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
ES2761558T3 (es)	2014-09-30	2020-05-20	Allergan Ind Sas	Composiciones de hidrogel estables que incluyen aditivos
FR3029928B1 (fr)	2014-12-15	2018-03-09	Teoxane	Gel reticule
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
PL3256179T3 (pl)	2015-02-13	2020-05-18	Allergan Industrie, Sas	Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
CZ309295B6 (cs)	2015-03-09	2022-08-10	Contipro A.S.	Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs)	2015-06-15	2017-02-08	Contipro A.S.	Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
US9737395B2 (en)	2015-06-26	2017-08-22	Phi Nguyen	Systems and methods for reducing scarring
CZ306662B6 (cs)	2015-06-26	2017-04-26	Contipro A.S.	Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
US10130578B2 (en)	2015-07-23	2018-11-20	Johnson & Johnson Consumer Inc.	Topical delivery of skin compositions having low pH
WO2017016917A1 (en)	2015-07-27	2017-02-02	Galderma Sa	A process for efficient cross-linking of hyaluronic acid
CZ308106B6 (cs)	2016-06-27	2020-01-08	Contipro A.S.	Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
TW201832783A (zh) *	2016-12-02	2018-09-16	法商賽諾菲公司	包含ｇｌｐ－１／胰高血糖素雙重激動劑、連接子和透明質酸的接合物
CN106750383B (zh) *	2016-12-20	2019-02-12	大连理工大学	聚乙二醇水凝胶材料及其制备方法
KR101944008B1 (ko) *	2017-09-18	2019-01-30	(주) 제이씨바이오	히알루론산을 포함하는 투명 하이드로겔 막 및 이를 이용한 콘택트렌즈
CN107936272B (zh) *	2017-11-27	2020-11-10	华熙生物科技股份有限公司	一种用于放疗防护的3d交联透明质酸盐凝胶的制备方法及其产品
ES2909623T3 (es) *	2017-12-29	2022-05-09	Matex Lab S P A	Procedimiento para preparar un relleno con una base de ácido hialurónico que comprende una etapa de neutralización
KR102823314B1 (ko) *	2018-05-08	2025-06-23	피디아 파마슈티치 에스.피.에이.	손상된 피부를 치료하기 위한 상처 드레싱
CN108774330B (zh) *	2018-08-30	2020-11-10	华熙生物科技股份有限公司	一种交联透明质酸凝胶的制备方法及所得产品和应用
CN112714644B (zh) *	2018-09-20	2024-03-29	香港科技大学	滴眼剂组合物
WO2020057606A1 (en) *	2018-09-20	2020-03-26	The Hong Kong University Of Science And Technology	Eyedrop compositions
KR102015857B1 (ko) *	2019-04-08	2019-08-30	(주)우성씨앤티	가교 히알루론산과 프리바이오틱스를 활성 성분으로 포함하는 화장품 조성물
EP3797800A1 (en) *	2019-05-02	2021-03-31	Institut National De La Sante Et De La Recherche Medicale - Inserm	Hyaluronic acid hydrogels with prolonged antimicrobial activity
EP3990040A4 (en) *	2019-06-26	2023-07-26	Lacerta Technologies Inc.	CROSS-LINKED HYALURONIC ACID HYDROGELS INCLUDING PROTEINS
CN111514364B (zh) *	2020-03-19	2022-06-10	中国人民解放军陆军军医大学第二附属医院	一种用于恶性血液病患者肛周感染的敷料及其制备方法
WO2021220195A1 (en) *	2020-04-28	2021-11-04	Nanofaber S.R.L.	Nanoporous microsponge particles (nmp) of biocompatible polymers as universal carriers for biomolecules delivery
CA3208574A1 (en) *	2021-02-16	2022-08-25	Prollenium Medical Technologies, Inc.	Cross-linked ha beads, process for making same and uses
CN114209869A (zh) *	2022-01-14	2022-03-22	北京极暖网络科技有限公司	自发热玻尿酸材料、制备方法及裤式卫生巾
CN118403006A (zh) *	2024-03-29	2024-07-30	上海利康瑞生物工程有限公司	交联玻璃酸钠注射液用于治疗骨关节炎的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US4716224A (en)	1984-05-04	1987-12-29	Seikagaku Kogyo Co. Ltd.	Crosslinked hyaluronic acid and its use
SE442820B (sv) *	1984-06-08	1986-02-03	Pharmacia Ab	Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) *	1984-12-06	1986-04-15	Biomatrix, Inc.	Cross-linked gels of hyaluronic acid and products containing such gels
US4713448A (en)	1985-03-12	1987-12-15	Biomatrix, Inc.	Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
DE3684887D1 (de) *	1985-11-29	1992-05-21	Biomatrix Inc	Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
JPS6345198A (ja)	1986-04-23	1988-02-26	Sumitomo Electric Ind Ltd	多元系結晶の製造方法
IT1198449B (it)	1986-10-13	1988-12-21	F I D I Farmaceutici Italiani	Esteri di alcoli polivalenti di acido ialuronico
US5017229A (en)	1990-06-25	1991-05-21	Genzyme Corporation	Water insoluble derivatives of hyaluronic acid
US5356883A (en)	1989-08-01	1994-10-18	Research Foundation Of State University Of N.Y.	Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5767079A (en) *	1992-07-08	1998-06-16	Celtrix Pharmaceuticals, Inc.	Method of treating ophthalmic disorders using TGF -β
US5866120A (en) *	1995-11-22	1999-02-02	Advanced Corneal Systems, Inc.	Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
IT1303735B1 (it) *	1998-11-11	2001-02-23	Falorni Italia Farmaceutici S	Acidi ialuronici reticolati e loro usi medici.
FR2827290B1 (fr) *	2001-07-13	2004-07-09	Pierre Jouan Biotechnologies Sa	Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
US7811806B2 (en) *	2001-12-21	2010-10-12	Novozymes, Inc.	Methods for producing hyaluronan in a recombinant host cell
US20050222081A1 (en)	2002-04-17	2005-10-06	Gianolio Diego A	Cross-linked hyaluronate compounds
AU2003303820A1 (en)	2003-01-31	2004-08-23	Biosphere S.P.A.	Water soluble and biocompatible gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters
MXPA06007556A (es) *	2003-12-30	2006-08-31	Genzyme Corp	Geles cohesivos de hialuronano y/o hilano entrecruzados, su preparacion y su uso.
CA2567532C (en)	2004-05-20	2013-10-01	Mentor Corporation	Methods for making injectable polymer hydrogels

2005
- 2005-11-24 DK DK05804061.9T patent/DK1817347T3/en active
- 2005-11-24 WO PCT/DK2005/000753 patent/WO2006056204A1/en not_active Ceased
- 2005-11-24 EP EP05804061.9A patent/EP1817347B1/en not_active Expired - Lifetime
- 2005-11-24 ES ES05804061.9T patent/ES2636998T3/es not_active Expired - Lifetime
- 2005-11-24 PL PL05804061T patent/PL1817347T3/pl unknown
- 2005-11-24 US US11/719,790 patent/US8481080B2/en active Active
- 2005-11-24 CN CN2005800471013A patent/CN101107270B/zh not_active Expired - Lifetime
- 2005-11-24 PT PT58040619T patent/PT1817347T/pt unknown
2013
- 2013-06-07 US US13/912,894 patent/US20130338100A1/en not_active Abandoned
2015
- 2015-01-07 US US14/591,522 patent/US20150190420A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1817347A1 (en)	2007-08-15
ES2636998T3 (es)	2017-10-10
DK1817347T3 (en)	2017-08-14
PT1817347T (pt)	2017-07-21
US20150190420A1 (en)	2015-07-09
US20090155362A1 (en)	2009-06-18
WO2006056204A1 (en)	2006-06-01
CN101107270A (zh)	2008-01-16
US8481080B2 (en)	2013-07-09
CN101107270B (zh)	2011-11-23
EP1817347B1 (en)	2017-05-17
WO2006056204A8 (en)	2006-08-24
US20130338100A1 (en)	2013-12-19

Publication	Publication Date	Title
PT1817347T (pt)	2017-07-21	Resumo
EP1818344A4 (en)	2012-04-18	METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL
PL1784375T3 (pl)	2010-10-29	Sposób wytwarzania kwasu mrówkowego
IL181303A0 (en)	2007-07-04	Method for the production of dihydropteridinones
IL197498A0 (en)	2009-12-24	Hyaluronic acid derivatives obtained via click chemistry' crosslinking
GB0614800D0 (en)	2006-09-06	Method of manufacture of polymer composites
TWI349660B (en)	2011-10-01	Process for producing acetic acid
IL182940A0 (en)	2008-01-20	Solid electrolyte and method of producing the same
IL176767A0 (en)	2006-10-31	Production method
GB0409610D0 (en)	2004-06-02	Improved method of settling commercial indebtedness
IL180742A0 (en)	2007-06-03	Method of manufacture
PL1903019T3 (pl)	2016-01-29	Sposób wytwarzania izoolefin
EP2003735A4 (en)	2012-01-18	END DEVICE AND METHOD FOR THE PRODUCTION THEREOF
IL171145A (en)	2010-12-30	Method for the production of telmisartan
TWI365182B (en)	2012-06-01	Process for producing acetic acid
ZA200609923B (en)	2009-08-26	2-butanol production method
PT2597175T (pt)	2016-11-16	Método para a produção de um polímero revestido
PL1794111T3 (pl)	2014-12-31	Sposób wytwarzania cyklopentanonu
ZA200709285B (en)	2008-11-26	Method for the production of pigs, and pigs
IL181339A0 (en)	2007-07-04	Method for the production of diarylcycloalkyl derivatives
SI2121649T1 (sl)	2013-06-28	Postopek za pripravo benzofuran-2 karboksamidov
TWI372158B (en)	2012-09-11	Method of producing film from polymer solution
ZA200700282B (en)	2008-06-25	Method for the production of dihydropteridinones
PL372014A1 (pl)	2006-07-10	Sposób wytwarzania kwasu 1-metylo-4-nitro-3-n-propylo-pirazolo-5-karboksylowego
PL364505A1 (pl)	2005-07-25	Sposób funkcjonalizacji kauczuków butadienowo-akrylonitrylowych grupami karboksylowymi